What is ICU Medical's market cap?

ICU Medical (ICUI) has a market capitalization of $3.9B and trades on NASDAQ.

What is ICU Medical's revenue and profitability?

ICU Medical generated $2.2B in trailing twelve-month revenue with net income of $46.6M, representing a net margin of -0.3%. Gross margin stands at 37.9%, with free cash flow of $91.2M. These figures are based on the Q1 2026 filing.

Who are ICU Medical's competitors?

ICU Medical's key competitors include Teleflex, Baxter International, AngioDynamics, and others. These companies compete in similar markets and product categories.

Who does ICU Medical partner with?

ICU Medical's notable partners include Otsuka Pharmaceutical Factory America, Inc., Pfizer Inc..

What subsidiaries does ICU Medical have?

ICU Medical's subsidiaries include Smiths Medical, Pursuit Vascular, Inc., Hospira Infusion Systems.

Where is ICU Medical headquartered?

ICU Medical is headquartered in United States of America and employs approximately 14,000 people. It has been publicly traded since 1992.

ICU Medical

ICUI

ICU Medical develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care applications.

Market cap

$3.93B+23.9%

Revenue$2.2B-10.9%

Net income$46.6M+140%

Free cash flow$91.2M-30.7%

EPS (diluted)$1.86+138%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$525.8MBeat by $5.1M EPS$1.97Beat by $0.19

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$533.4M

EPS estimate$1.91

Financials

Q1 2026

Income statement

See full

Revenue$530.2M-12.3%

Gross profit$206.2M-1.8%

Operating income$13.6M+5.4%

Net income$30.1M+295%

EPS (diluted)$1.20+290%

Balance sheet

See full

Cash & equivalents$288.3M-0.5%

Total debt$1.4B-17.5%

Total equity$2.1B+6.3%

Total assets$4.0B-4.1%

Cash flow

See full

Operating cash flow$38.9M-24.2%

CapEx$11.3M-22.7%

Free cash flow$27.6M-24.8%

Valuation & ratios

Valuation

See full

Market cap$3.93B+23.9%

Enterprise value$5.01B+17.0%

P/E84.5×—

P/S1.8×+0.5×

Profitability

See full

Gross margin37.9%+2.8pp

Operating margin2%-0.7pp

FCF margin4.2%-1.2pp

Returns & leverage

See full

Debt / equity0.6×-0.2×

Current ratio2.3×-0.3×

Competitors

By market cap

Medtronic$104.82B-11.1%

Edwards Lifesciences$48.6B+7.7%

Becton, Dickinson and Company$42.2B-19.4%

Moog$12.8B—

Baxter International$11.2B-23.4%

TFX

Teleflex$6.0B+15.2%

ICU Medical$3.9B+23.9%

AngioDynamics$571.2M+52.6%

By revenue growth

TFX

Teleflex+25.0%

Edwards Lifesciences+14.5%

Moog+13.5%

AngioDynamics+9.5%

Medtronic+8.4%

Becton, Dickinson and Company+6.4%

Baxter International+5.1%

ICU Medical-10.9%

By net margin

Edwards Lifesciences15.43%-57.5pp

Medtronic13.2%-0.7pp

Moog6.8%+1.0pp

Becton, Dickinson and Company5.33%-2.1pp

ICU Medical-0.317%+7.0pp

Baxter International-9.7%-4.5pp

AngioDynamics-11.48%+0.1pp

TFX

Teleflex-47.43%-56.2pp

Profile

ICU Medical develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care applications. The company provides a comprehensive portfolio of IV pumps, safety software, and consumables designed to enhance patient safety and clinical efficiency in hospital and alternate site settings. Its value proposition centers on being a 'one-stop shop' for integrated infusion systems and critical care products globally.

Competitive position

A leading global provider of integrated infusion therapy systems with a strong emphasis on cybersecurity-certified smart pumps and closed-system transfer devices.

GeographiesUnited States, Costa Rica, Mexico, Czech Republic, India

Customer segmentsAcute Care Hospitals, Ambulatory Surgery Centers, Home Healthcare, Wholesalers

Business modelManufacturing, Direct Sales, Software-as-a-Service, Professional Services

SuppliersRaw material suppliers (plastics, electronics), Contract manufacturers, Single-source component suppliers

CustomersMedical product wholesalers, Independent distributors, Hospital systems, Alternate site healthcare facilities

CountryUnited States of America

Listed1992

Employees14.0K

CEOVivek Jain

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websiteicumed.com

FilingsSEC EDGAR

Ask your AI about ICU Medical.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ICU Medical's market cap?: ICU Medical (ICUI) has a market capitalization of $3.9B and trades on NASDAQ.
What is ICU Medical's revenue and profitability?: ICU Medical generated $2.2B in trailing twelve-month revenue with net income of $46.6M, representing a net margin of -0.3%. Gross margin stands at 37.9%, with free cash flow of $91.2M. These figures are based on the Q1 2026 filing.
Who are ICU Medical's competitors?: ICU Medical's key competitors include Teleflex, Baxter International, AngioDynamics, and others. These companies compete in similar markets and product categories.
Who does ICU Medical partner with?: ICU Medical's notable partners include Otsuka Pharmaceutical Factory America, Inc., Pfizer Inc..
What subsidiaries does ICU Medical have?: ICU Medical's subsidiaries include Smiths Medical, Pursuit Vascular, Inc., Hospira Infusion Systems.
Where is ICU Medical headquartered?: ICU Medical is headquartered in United States of America and employs approximately 14,000 people. It has been publicly traded since 1992.